Announce Date | 02/26/2025 |
EPS Normalized Actual | $1.31 (Beat by $0.03) |
EPS GAAP Actual | $1.31 (Beat by $0.03) |
Revenue Actual | $1.681B |
Revenue Surprise | Beat by $1681M |
Announce Date | 01/31/2025 (Pre-Market) |
EPS Normalized Estimate | $1.43101 |
EPS GAAP Estimate | $1.43101 |
Revenue Estimate | $1.765001949B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2029 | 7.63 | 15.38 | 7.54677 | 7.71988 | 1 |
Oct 2028 | 7.59 | 15.46 | 7.45627 | 7.78845 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.12 | -0.31101 | 1.681B | 1.37% | -84M |
FQ4 2024 (Oct 2024) | 1.23 | 1.23 | 1.701B | 0.76% | 1701M |
FQ3 2024 (Jul 2024) | 0.97 | 0.97 | 1.578B | -5.96% | 1578M |
FQ2 2024 (Apr 2024) | 1.05 | 1.05 | 1.573B | -9.15% | 1573M |
FQ1 2024 (Jan 2024) | 1.18 | 1.18 | 1.658B | -5.91% | 1658M |
FQ4 2023 (Oct 2023) | 1.63 | 1.63 | 1.688B | -9.54% | 1688M |
FQ3 2023 (Jul 2023) | 0.38 | 0.38 | 1.672B | -2.75% | 1672M |
FQ2 2023 (Apr 2023) | 1.02 | 1.02 | 1.717B | 100% | 1717M |
FQ4 Announce Date
01/31/2025 (Pre-Market)
Consensus EPS Estimates
1.43101
Consensus Revenue Estimates
1.765001949B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 1.70585 | -- | 1.68635 | 1.71951 | 3 |
FQ2 2027 (Apr 2027) | 1.58394 | -- | 1.56583 | 1.59663 | 5 |
FQ1 2027 (Jan 2027) | 1.55918 | -- | 1.54136 | 1.57167 | 3 |
FQ4 2026 (Oct 2026) | 1.92167 | -- | 1.89025 | 1.94524 | 4 |
FQ3 2026 (Jul 2026) | 1.70202 | -- | 1.67419 | 1.72289 | 4 |
FQ2 2026 (Apr 2026) | 1.51907 | -- | 1.49423 | 1.5377 | 4 |
FQ1 2026 (Jan 2026) | 1.56528 | 28.45 | 1.46448 | 1.59715 | 3 |
FQ4 2025 (Oct 2025) | 1.71698 | 28.36 | 1.6889 | 1.73804 | 5 |
FQ3 2025 (Jul 2025) | 1.59373 | 39.14 | 1.56767 | 1.61327 | 5 |
FQ2 2025 (Apr 2025) | 1.43113 | 26.63 | 1.40773 | 1.44868 | 5 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 1.92B | -- | 1.9B | 1.93B | 4 |
FQ2 2027 (Apr 2027) | 1.87B | -- | 1.86B | 1.89B | 6 |
FQ1 2027 (Jan 2027) | 1.9B | -- | 1.88B | 1.91B | 4 |
FQ4 2026 (Oct 2026) | 2.08B | -- | 2.05B | 2.1B | 5 |
FQ3 2026 (Jul 2026) | 1.94B | -- | 1.92B | 1.96B | 4 |
FQ2 2026 (Apr 2026) | 1.83B | -- | 1.81B | 1.85B | 8 |
FQ1 2026 (Jan 2026) | 1.83B | 8.03 | 1.74B | 1.86B | 4 |
FQ4 2025 (Oct 2025) | 1.91B | 10.99 | 1.89B | 1.93B | 3 |
FQ3 2025 (Jul 2025) | 1.79B | 12.02 | 1.77B | 1.81B | 3 |
FQ2 2025 (Apr 2025) | 1.71B | 7.96 | 1.69B | 1.73B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.43101 | 1.12 | -0.31101 | -27.77% |
FQ4 2024 (Oct 2024) | 1.23 | 1.23 | 100% | |
FQ3 2024 (Jul 2024) | 0.97 | 0.97 | 100% | |
FQ2 2024 (Apr 2024) | 1.05 | 1.05 | 100% | |
FQ1 2024 (Jan 2024) | 1.18 | 1.18 | 100% | |
FQ4 2023 (Oct 2023) | 1.63 | 1.63 | 100% | |
FQ3 2023 (Jul 2023) | 0.38 | 0.38 | 100% | |
FQ2 2023 (Apr 2023) | 1.02 | 1.02 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $1.77B | $1.68B | $-84M | -5% |
FQ4 2024 (Oct 2024) | $0B | $1.7B | $1701M | 100% |
FQ3 2024 (Jul 2024) | $0B | $1.58B | $1578M | 100% |
FQ2 2024 (Apr 2024) | $0B | $1.57B | $1573M | 100% |
FQ1 2024 (Jan 2024) | $0B | $1.66B | $1658M | 100% |
FQ4 2023 (Oct 2023) | $0B | $1.69B | $1688M | 100% |
FQ3 2023 (Jul 2023) | $0B | $1.67B | $1672M | 100% |
FQ2 2023 (Apr 2023) | $0B | $1.72B | $1717M | 100% |